Healthcare -
Biotechnology - NASDAQ - US
$ 91.935
-1.87 %
$ 4.46 B
Market Cap
-13.97
P/E
AXSM - COST OF REVENUE
Cost of Revenue AXSM - Axsome Therapeutics, Inc.
26.1 M
LAST VALUE
374.91%
2 YEAR CAGR
250.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR